HSCA hires new President & CEO

April 3, 2019

The Healthcare Supply Chain Association (HSCA) Board of Directors announced yesterday that it has named healthcare expert Khatereh Calleja as President and CEO of HSCA, effective April 29, 2019. In her prior role as Senior Vice President of Technology and Regulatory Affairs at AdvaMed, the association that represents medical devices, diagnostic products, and medical information systems, HSCA feels confident that the veteran executive will have much to contribute to the organization’s mission.

“Khatereh has been at the forefront of some of the most critical healthcare debates in Washington and her profound knowledge of health policy, her passion for communicating about the value of the supply chain, and her reputation as a bridge-builder in Washington will help drive our advocacy on behalf of the supply chain and the providers and patients we serve,” said Lee Perlman, GNYHA Ventures President and HSCA Board Chair in a prepared statement. “The entire supply chain will benefit from Khatereh’s leadership, forward-looking vision, and deep healthcare expertise, and we are thrilled that Khatereh has chosen to begin the next chapter of her outstanding career as the head of HSCA.”

While at AdvaMed, Calleja, a graduate of Emory University and the Villanova University School of Law, led a wide range of policy and legal-regulatory priorities focusing on Congress, the Department of Health and Human Services (HHS), the U.S. Food and Drug Administration (FDA), the Federal Trade Commission (FTC), and the Administration.

After a 40-year career, outgoing HSCA President and CEO Todd Ebert, RPh, is retiring and moving back to St. Louis, according the ASCA announcement.

“We are grateful to Todd for his leadership, service to the industry, and friendship, and for all he has done to move the organization and the industry at large forward,” Perlman stated. “Todd has helped establish HSCA as the leading advocate in Washington for the healthcare supply chain and he leaves the organization in a strong position to continue to advocate for health policy that improves care.”